CN Stock MarketDetailed Quotes
688068 Beijing Hotgen Biotech Co.,Ltd
Watchlist
45.08
+1.00+2.27%
Market Closed 12/01 15:00 CST
45.39High43.79Low23.15KlotVolume
44.38Open44.08Pre Close103.57MTurnover2.51%Turnover RatioLossP/E (TTM)4.16BMarket Cap100.7952wk High4.40P/E (Static)92.27MShares35.7052wk Low1.22P/B4.16BFloat Cap161.49Historical High52.90Limit Up92.27MShs Float18.78Historical Low35.26Limit Down3.63%Amplitude10.48KlotAsk--Dividend TTM44.74Avg Price12.49KlotBid--Div YieldTTM100Lot Size
Beijing Hotgen Biotech Co.,Ltd Key Stats
EPS
According to the latest financial report of Beijing Hotgen Biotech Co.,Ltd, the latest earnings per share (TTM) for the company is 0.61. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: CNY
Cumulative Quarterly
Loading...
BVPS
Analyzing a company's fundamentals? Check out Beijing Hotgen Biotech Co.,Ltd's latest financial report to see how much their book value per share (BVPS) is currently at 36.86.
Currency: CNY
Cumulative Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Beijing Hotgen Biotech Co.,Ltd shows that the company's current ratio is 5.51, indicating healthy liquidity.
Cumulative Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Beijing Hotgen Biotech Co.,Ltd, the quick ratio is 4.70, indicating that the company can meet its short-term debt obligations.
Cumulative Quarterly
Loading...
ROE
Want to learn more about the financial health of Beijing Hotgen Biotech Co.,Ltd? The latest ROE figure is 1.61%, indicating that the company has stable profitability.
Cumulative Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Beijing Hotgen Biotech Co.,Ltd, the total asset return on investment (ROA) is 1.25%.
Cumulative Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Beijing Hotgen Biotech Co.,Ltd's latest financial report to see how their gross margin is doing - currently at 64.10%.
Cumulative Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Beijing Hotgen Biotech Co.,Ltd, the net profit margin is 11.53%, which is a good sign for its profitability.
Cumulative Quarterly
Loading...
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.